30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

Interventional Spine Receives FDA Clearance for Next-generation Opticage -

Interventional Spine received FDA clearance for a next-generation design of its Opticage® Expandable Interbody Fusion Device, and expects product to ship in early 1Q16.

New features include improved ergonomics and delivery of graft through the implant after expansion, as well as a more streamlined profile. A full line of sizes will be provided sterile to address all common surgical approaches to fusion. 

Cleared in 1Q12, the original Opticage has been implanted nearly 2,000 times worldwide since market release in mid-2012.

Source: Interventional Spine, Inc.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.